July 25, 2017 / 11:29 AM / 2 years ago

BRIEF-Compugen announces issuance of U.S. patent for COM701, its lead immuno-oncology product candidate

July 25 (Reuters) - Compugen Ltd

* Compugen Ltd - patent is expected to expire no earlier than February 2036 in U.S. for issued claims Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below